Verrica Pharmaceuticals Inc. Quarterly Cost of Revenue in USD from Q3 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Verrica Pharmaceuticals Inc. quarterly/annual Cost of Revenue history and growth rate from Q3 2023 to Q3 2024.
  • Verrica Pharmaceuticals Inc. Cost of Revenue for the quarter ending September 30, 2024 was $400K, a 33.3% increase year-over-year.
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $400K +$100K +33.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $700K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $700K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q3 2023 $300K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.